Phase II data for Labopharm's Xopenex

Labopharm (TSE:DDS) said a Phase II trial

Read the full 72 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE